Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity

13 Sept 2022

Abstract excerpt

As of November 2021, several SARS-CoV-2 variants appeared and became dominant epidemic strains in many countries, including five variants of concern (VOCs) Alpha, Beta, Gamma, Delta, and Omicron defined by the World Health Organization during the COVID-19 pandemic. As of August 2022, Omicron is classified into five main lineages, BA.1, BA.2, BA.3, BA.4, BA.5 and some sublineages (BA.1.1, BA.2.12.1, BA.2.11,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36097349
DOI: 10.1002/jmv.28138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivityPMID 36097349Read ↗

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesSemantic proximity Read ↗

SARS-CoV-2 vaccine-breakthrough infections (VBIs) by Omicron (B.1.1.529) variant and consequences in structural and functional impactSemantic proximity Read ↗

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature ReviewSemantic proximity Read ↗

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and preventionSemantic proximity Read ↗

"Is Omicron mild"? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies.Semantic proximity Read ↗

<strong>Efficacy of COVID-19 Vaccines Against the Omicron Variant of SARS-CoV-2</strong>Semantic proximity Read ↗

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics.Semantic proximity Read ↗

COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2Semantic proximity Read ↗

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution DynamicsSemantic proximity Read ↗

Association Between Clinical Manifestations, Outcomes, And Different Vaccination Regimens in Patients with Omicron Breakthrough Infection: A Real-World Cohort StudySemantic proximity Read ↗

Omicron - The new SARS-CoV-2 challenge?Semantic proximity Read ↗

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.